Skip to main content
FinSpry Logo
FinSpry
PHAT logo
PHAT
(NASDAQ)
Phathom Pharmaceuticals, Inc.
$11.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Phathom Pharmaceuticals (PHAT) Stock Price & Financial Analysis

Phathom Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.80 - $11.37
52-Week High$18.31
52-Week Low$2.21
Open$10.91
Volume786.35K
Average Volume (3M)786.35K
Market Cap826.90M
Shares Outstanding72.92M
Price to Sales (P/S)4.64
EV/EBITDA-13.95
Revenue (TTM)175.11M
Net Income (TTM)-221.25M
Free Cash Flow (TTM)-166.80M
EPS (TTM)$-3.03
Profit Margin-126.35%
Operating Margin-91.36%
50-Day MA$11.93
200-Day MA$12.28
52-Week Change117.58%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Phathom Pharmaceuticals

What is the current stock price for PHAT?

As of the latest trading session, PHAT stock trades at $11.34. The 52-week range is $2.21–$18.31, with a day range of $10.80–$11.37.

What is the P/E ratio for PHAT?

The P/E ratio (Price-to-Earnings) for PHAT is shown in the Key Statistics section. This valuation metric helps compare Phathom Pharmaceuticals, Inc. to industry peers.

Does PHAT pay dividends?

Phathom Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAT?

Based on 2 analysts, the consensus for PHAT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PHAT?

Phathom Pharmaceuticals's market capitalization is $826.9M, classifying it as a small-cap company. Phathom Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.